The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts — Role of late sodium current and intracellular ion accumulation
Open accessAbstract
The goal of this study was to test the hypothesis that the novel anti-ischemic drug ranolazine, which is known to inhibit late I(Na), could reduce intracellular [Na(+)](i) and diastolic [Ca(2+)](i) overload and improve diastolic function. Contractile dysfunction in human heart failure (HF) is associated with increased [Na(+)](i) and elevated diastolic [Ca(2+)](i). Increased Na(+) influx through voltage-gated Na(+) channels (late I(Na)) has been suggested to contribute to elevated [Na(+)](i) in HF. In isometrically contracting ventricular muscle strips from end-stage failing human hearts, ranolazine (10 micromol/L) did not exert negative inotropic effects on twitch force amplitude. However, ranolazine significantly reduced frequency-dependent increase in diastolic tension (i.e., diastolic dysfunction) by approximately 30% without significantly affecting sarcoplasmic reticulum (SR) Ca(2+) loading. To investigate the mechanism of action of this beneficial effect of ranolazine on diastolic tension, Anemonia sulcata toxin II (ATX-II, 40 nmol/L) was used to increase intracellular Na(+) loading in ventricular rabbit myocytes. ATX-II caused a significant rise in [Na(+)](i) typically seen in heart failure via increased late I(Na). In parallel, ATX-II significantly increased diastolic [Ca(2+)](i). In the presence of ranolazine the increases in late I(Na), as well as [Na(+)](i) and diastolic [Ca(2+)](i) were significantly blunted at all stimulation rates without significantly decreasing Ca(2+) transient amplitudes or SR Ca(2+) content. In summary, ranolazine reduced the frequency-dependent increase in diastolic tension without having negative inotropic effects on contractility of muscles from end-stage failing human hearts. Moreover, in rabbit myocytes the increases in late I(Na), [Na(+)](i) and [Ca(2+)](i) caused by ATX-II, were significantly blunted by ranolazine. These results suggest that ranolazine may be of therapeutic benefit in conditions of diastolic dysfunction due to elevated [Na(+)](i) and diastolic [Ca(2+)](i).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Excitation-Contraction Coupling and Cardiac Contractile Force
Bers, D. M., & Zhu, Y. (2010) · Journal of Cardiovascular Disease Research · doi:10.1016/s0975-3583(10)11011-0 · Cited by 1,603
Excitation-Contraction Coupling and Cardiac Contractile Force
Bers, D. M. (1993) · Developments in Cardiovascular Medicine · doi:10.1007/978-94-017-1512-6 · Cited by 772
Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties
Antzelevitch, C., Belardinelli, L., Zygmunt, A. C., Burashnikov, A., Di Diego, J. M., Fish, J. M., Cordeiro, J. M., & Thomas, G. (2004) · Circulation · doi:10.1161/01.cir.0000139333.83620.5d · Cited by 675
Self-citationChaitman, B. R., Skettino, S. L., Parker, J. O., Hanley, P., Meluzin, J., Kuch, J., Pepine, C. J., Wang, W., Nelson, J. J., Hebert, D. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.045 · Cited by 567
Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels
Wagner, S., Dybkova, N., Rasenack, E. C. L., Jacobshagen, C., Fabritz, L., Kirchhof, P., Maier, S. K. G., Zhang, T., Hasenfuss, G., Brown, J. H., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26620 · Cited by 553
Self-citationValdivia, C. R., Chu, W. W., Pu, J., Foell, J. D., Haworth, R. A., Wolff, M. R., Kamp, T. J., & Makielski, J. C. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.12.012 · Cited by 441
Hasenfuss, G., Schillinger, W., Lehnart, S. E., Preuss, M., Pieske, B., Maier, L. S., Prestle, J., Minami, K., & Just, H. (1999) · Circulation · doi:10.1161/01.cir.99.5.641 · Cited by 409
Self-citationBelardinelli, L., Shryock, J. C., & Fraser, H. (2006) · Heart · doi:10.1136/hrt.2005.078790 · Cited by 386
Self-citationPieske, B., Maier, L. S., Bers, D. M., & Hasenfuss, G. (1999) · Circulation Research · doi:10.1161/01.res.85.1.38 · Cited by 369 · cited 3×
“To assess whether the effect of ranolazine on diastolic tension resulted from improved SR Ca uptake resulting in increased SR Ca load, post-rest behavior was evaluated at different rest intervals [25].”
BackgroundMethodSelf-citationIntracellular Na + Concentration Is Elevated in Heart Failure But Na/K Pump Function Is Unchanged
Despa, S., Islam, M. A., Weber, C. R., Pogwizd, S. M., & Bers, D. M. (2002) · Circulation · doi:10.1161/01.cir.0000016701.85760.97 · Cited by 319
Novel, Ultraslow Inactivating Sodium Current in Human Ventricular Cardiomyocytes
Maltsev, V. A., Sabbah, H. N., Higgins, R. S. D., Silverman, N., Lesch, M., & Undrovinas, A. I. (1998) · Circulation · doi:10.1161/01.cir.98.23.2545 · Cited by 310
Rate Dependence of [Na + ] i and Contractility in Nonfailing and Failing Human Myocardium
Pieske, B., Maier, L. S., Piacentino, V., Weisser, J., Hasenfuss, G., & Houser, S. (2002) · Circulation · doi:10.1161/01.cir.0000023042.50192.f4 · Cited by 305
Self-citationHypoxia increases persistent sodium current in rat ventricular myocytes.
Ju, Y. K., Saint, D. A., & Gage, P. W. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021772 · Cited by 281
Song, Y., Shryock, J. C., Wagner, S., Maier, L. S., & Belardinelli, L. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101832 · Cited by 276
Self-citationUNDROVINAS, A. I., BELARDINELLI, L., UNDROVINAS, N. A., & SABBAH, H. N. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00401.x · Cited by 266
Self-citationBers, D. M. (1985) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1985.248.3.h366 · Cited by 250
Undrovinas, A. I., Fleidervish, I. A., & Makielski, J. C. (1992) · Circulation Research · doi:10.1161/01.res.71.5.1231 · Cited by 241
Song, Y., Shryock, J. C., Wu, L., & Belardinelli, L. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200408000-00008 · Cited by 211
Self-citationKohlhaas, M., Zhang, T., Seidler, T., Zibrova, D., Dybkova, N., Steen, A., Wagner, S., Chen, L., Heller Brown, J., Bers, D. M., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000200739.90811.9f · Cited by 200
Self-citationUndrovinas, A. I., Maltsev, V. A., & Sabbah, H. N. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050306 · Cited by 199
Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes.
Ward, C. A., & Giles, W. R. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp022048 · Cited by 196
Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading.
Haigney, M. C., Lakatta, E. G., Stern, M. D., & Silverman, H. S. (1994) · Circulation · doi:10.1161/01.cir.90.1.391 · Cited by 195
Antiarrhythmic Effects of Ranolazine in a Guinea Pig in Vitro Model of Long-QT Syndrome
Wu, L., Shryock, J. C., Song, Y., Li, Y., Antzelevitch, C., & Belardinelli, L. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066100 · Cited by 193
Self-citationMaltsev, V. A., Silverman, N., Sabbah, H. N., & Undrovinas, A. I. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.08.007 · Cited by 189
Molecular basis of ranolazine block of LQT‐3 mutant sodium channels: evidence for site of action
Fredj, S., Sampson, K. J., Liu, H., & Kass, R. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706709 · Cited by 168
Sabbah, H. N., Chandler, M. P., Mishima, T., Suzuki, G., Chaudhry, P. A., Nass, O., Biesiadecki, B. J., Blackburn, B. K., Wolff, A. A., & Stanley, W. C. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.129232 · Cited by 143
Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts
FRASER, H., Belardinelli, L., Wang, L., LIGHT, P., McVeigh, J., & Clanachan, A. S. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.012 · Cited by 141
Self-citationCardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart
Gralinski, M., Black, S. C., Kilgore, K. S., Chou, A. Y., McCormack, J. G., & Lucchesi, B. R. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.8.1231 · Cited by 95
Late Sodium Current is a Novel Target for Amiodarone: Studies in Failing Human Myocardium
Maltsev, V. A., Sabbah, H. N., & Undrovinas, A. I. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1355 · Cited by 92
Isenberg, G., & Ravens, U. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015493 · Cited by 90
Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome
Clancy, C. E., Tateyama, M., & Kass, R. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215928 · Cited by 85
Na+ Current in Human Ventricle: Implications for Sodium Loading and Homeostasis
Makielski, J. C., & Farley, A. L. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00380.x · Cited by 85
Na channels that remain open throughout the cardiac action potential plateau
Liu, Y. M., DeFelice, L. J., & Mazzanti, M. (1992) · Biophysical Journal · doi:10.1016/s0006-3495(92)81635-1 · Cited by 57
Effect of hydrogen peroxide on persistent sodium current in guinea pig ventricular myocytes1
Ma, J., Luo, A., & Zhang, P. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00154.x · Cited by 56
Matsumura, H., Hara, A., Hashizume, H., Maruyama, K., & Abiko, Y. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.77.31 · Cited by 39
Maruyama, K., Hara, A., Hashizume, H., Ushikubi, F., & Abiko, Y. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774381 · Cited by 30
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Borlaug, B. A., & Paulus, W. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq426 · Cited by 1,093
Jaswal, J. S., Keung, W., Wang, W., Ussher, J. R., & Lopaschuk, G. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.015 · Cited by 400
Senni, M., Paulus, W. J., Gavazzi, A., Fraser, A. G., Diez, J., Solomon, S. D., Smiseth, O. A., Guazzi, M., Lam, C. S. P., Maggioni, A. P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu204 · Cited by 355
Altered Na+Currents in Atrial Fibrillation
Sossalla, S., Kallmeyer, B., Wagner, S., Mazur, M., Maurer, U., Toischer, K., Schmitto, J. D., Seipelt, R., Schöndube, F. A., Hasenfuss, G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.055 · Cited by 271
Self-citation
Metadata
- Authors
- Sossalla, S., Wagner, S., Rasenack, E. C. L., Ruff, H., Weber, S. L., Schöndube, F. A., Tirilomis, T., Tenderich, G., Hasenfuss, G., Belardinelli, L., & Maier, L. S.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 45
- Issue
- 1
- Pages
- 32-43
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2063954755
- Cited by
- 262
- References
- 38
- FWCI
- 16.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.